Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 1:55:101516.
doi: 10.1016/j.ijcha.2024.101516. eCollection 2024 Dec.

Impact of overweight and obesity on radiation dose and outcome in patients undergoing pulmonary vein isolation by cryoballoon and pulsed field ablation

Affiliations

Impact of overweight and obesity on radiation dose and outcome in patients undergoing pulmonary vein isolation by cryoballoon and pulsed field ablation

Christiane Jungen et al. Int J Cardiol Heart Vasc. .

Abstract

Background: Pulmonary vein isolation (PVI) using pulsed field ablation (PFA) or cryoballoon ablation (CBA) are commonly used single-shot techniques for the treatment of patients with atrial fibrillation (AF). The number of overweight (BMI 25-30 kg/m2) and obese (BMI>30 kg/m2) patients undergoing PVI is increasing, but data on this patient population is limited.

Methods: Consecutive AF patients with a BMI ≥25 kg/m2 undergoing PFA- or CBA-PVI were included in this retrospective analysis. Baseline characteristics, procedural parameters and 1-year AF-freedom were retrospectively analyzed and compared for both ablation modalities.

Results: Of 115 patients (66 % men, 64 years [IQR: 58-71 years], 57 % overweight and 43 % obese) PFA- was performed in 68 % and CBA-PVI in 32 %. Contrast-dye volume (PFA: 80 ml [IQR: 60 - 117 ml] vs. CBA: 130 ml [IQR: 95 - 200 ml], P=0.001) and radiation exposure (PFA: 2196 cGy·cm2 [IQR: 1398 - 2973 cGy·cm2] vs. CBA: 3239 cGy·cm2 [IQR: 1288 - 5062 cGy·cm2], P=0.009) was lower in patients undergoing PFA-PVI. Logistic regression analysis identified obesity (OR: 5.58, 95 % CI: 1.63-19.06; P=0.006) and CBA-PVI (OR: 12.93, 95 % CI: 3.51-47.68; P <0.001) to be associated with increased radiation exposure. Both techniques were comparably safe (PFA: 4 % vs. CBA: 0 %; P=0.3). The median follow-up time was 145 days [IQR: 103 - 294 days]. AF-freedom after 1-year was similar in overweight (82 %) and obese patients (67 %) (HR: 0.61; 95 % CI: 0.29-1.28; P=0.19) as well as in PFA- and CBA-PVI patients (76 % vs. 76 %, HR: 1.37; 95 % CI: 0.63-2.99; P=0.42).

Conclusion: Overweight and obese patients undergoing PFA-PVI had lower contrast-dye volume compared to CBA-PVI. Obesity was associated with increased radiation exposure. Both techniques were comparably safe. The 1-year AF-freedom was similar in overweight and obese patients.

Keywords: Atrial fibrillation; Catheter ablation; Obesity; Pulmonary vein isolation; Pulsed field ablation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Kaplan-Meier Curve distinguishing between atrial fibrillation patients that underwent PFA- or CBA-PVI. The initial 90 days after the procedure denote the blanking period. Freedom from atrial fibrillation 1-year after catheter ablation is similar in patients undergoing CBA- or PFA-PVI. CBA, Cryoballoon ablation; PFA, pulsed field ablation; PVI, pulmonary vein isolation.

References

    1. Hindricks G., Potpara T., Dagres N., Arbelo E., Bax J.J., Blomstrom-Lundqvist C., et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur. Heart J. 2021;42(5):373–498. - PubMed
    1. Javed S., Gupta D., Lip G.Y.H. Obesity and atrial fibrillation: Making inroads through fat. Eur. Heart J. Cardiovasc. Pharmacother. 2021;7(1):59–67. - PubMed
    1. Lavie C.J., Pandey A., Lau D.H., Alpert M.A., Sanders P. Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: Effects of weight loss and exercise. J. Am. Coll. Cardiol. 2017;70(16):2022–2035. - PubMed
    1. Gawalko M., Saljic A., Li N., Abu-Taha I., Jespersen T., Linz D., et al. Adiposity-associated atrial fibrillation: molecular determinants, mechanisms, and clinical significance. Cardiovasc. Res. 2023;119(3):614–630. - PMC - PubMed
    1. Sivasambu B., Balouch M.A., Zghaib T., Bajwa R.J., Chrispin J., Berger R.D., et al. Increased rates of atrial fibrillation recurrence following pulmonary vein isolation in overweight and obese patients. J. Cardiovasc. Electrophysiol. 2018;29(2):239–245. - PubMed

LinkOut - more resources